-
Mashup Score: 91Home Page: Journal of Cardiac Failure - 2 month(s) ago
Diversity, equity, inclusion , and belonging are core values for the Journal of Cardiac Failure. Improving the lives of our patients and their partners is the reason behind all we do at JCF. The Journal of Cardiac Failure (JCF) publishes the highest quality science in the field of heart failure with a focus on diversity, equity, and inclusion, mentorship, multidisciplinary partnerships, and patient-centeredness. Published papers span original investigator-initiated work to state-of-the-art reviews,
Source: onlinejcf.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 10JCF Ignite: Obesity and Heart Failure: A New Era Begins - 2 month(s) ago
Over half of patients with heart failure (HF) have a preserved left ventricular ejection fraction (HFpEF), and roughly two-thirds of those individuals are living with obesity.1 Initially considered to be a bystander, it is now clear that obesity plays a pivotal causal role in HFpEF. The amount of excess body fat, particularly visceral fat, is associated with the degree of systemic inflammation, cardiac dysfunction, chamber remodeling, volume overload, blood volume redistribution, and elevation in cardiac filling pressures.
Source: onlinejcf.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 10JCF Ignite: Obesity and Heart Failure: A New Era Begins - 2 month(s) ago
Over half of patients with heart failure (HF) have a preserved left ventricular ejection fraction (HFpEF), and roughly two-thirds of those individuals are living with obesity.1 Initially considered to be a bystander, it is now clear that obesity plays a pivotal causal role in HFpEF. The amount of excess body fat, particularly visceral fat, is associated with the degree of systemic inflammation, cardiac dysfunction, chamber remodeling, volume overload, blood volume redistribution, and elevation in cardiac filling pressures.
Source: onlinejcf.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 89Interventional Heart Failure: Current State of the Field - 2 month(s) ago
Despite important advancements in medical therapy, significant limitations persist in the treatment of heart failure (HF) with incomplete response to medical therapy, preserved ejection fraction and chronic kidney disease.1,2 Effective therapies in acute heart failure are even more limited, especially impacting patients with diuretic resistance and cardiogenic shock.1
Source: onlinejcf.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 73Improving Guideline-Directed Medical Therapy for Patients With Heart Failure With Reduced Ejection Fraction: A Review of Implementation Strategies - 3 month(s) ago
Heart failure with reduced ejection fraction (HFrEF) affects approximately 6.5 million people in the United States and is associated with high levels of morbidity and mortality, with projected mortality at 6 years approaching 50%.1 Use of guideline-directed medical therapy (GDMT) in HFrEF reduces the high morbidity and mortality rates associated with HFrEF.2–4 These medications include 4 groups of medications: (1) beta-blockers; (2) renin-angiotensin-aldosterone system (RAAS) inhibitors, such as angiotensin-converting enzyme inhibitors (ACEis), angiotensin receptor blockers (ARBs) and angiotensin-receptor neprilysin inhibitors (ARNIs); (3) mineralocorticoid receptor antagonists (MRAs); and (4) sodium-glucose cotransporter 2 inhibitors (SGLT2is).
Source: onlinejcf.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 61
Heart failure (HF) and type 2 diabetes mellitus (T2DM) commonly coexist; the presence of 1 condition portends adverse prognosis and heightened risk of clinical events for the other.1,2 In recent years, both HF and T2DM have an expanded set of available disease-modifying therapies that improve metabolic status, quality of life, hospitalization risk and, in some cases, risk of mortality. In addition, particular therapies such as the sodium glucose cotransporter-2 (SGLT2) inhibitors improve glycemic indices, lower risk for future cardiovascular events in those with T2DM and also show recent evidence supporting reduced morbidity and mortality rates in patients with HF.
Source: onlinejcf.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 75Being Well while Doing Well — Distinguishing Necessary from Unnecessary Discomfort in Training | NEJM - 3 month(s) ago
Medicine and Society from The New England Journal of Medicine — Being Well while Doing Well — Distinguishing Necessary from Unnecessary Discomfort in Training
Source: www.nejm.orgCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 15
Many randomized trials in cardiovascular disease have repeat nonfatal events (such as hospitalizations) occurring during patient follow-up; yet, it remains common practice to have time-to-first event as the primary outcome. We explore the value of analyses that include repeat events. Do they help us …
Source: pubmed.ncbi.nlm.nih.govCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 45
Medical decisions can be complicated and lead to confusion, particularly from a patient perspective. Scientific publications used to guide care are frequently not accessible to patients due to limited access, complicated statistical plans, and challenging to interpret medical terms. Improving knowledge through better education about scientific publications in heart failure may help patients feel more informed and empowered to ask questions and be part of the decision-making process around their care.
Source: onlinejcf.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 45
Medical decisions can be complicated and lead to confusion, particularly from a patient perspective. Scientific publications used to guide care are frequently not accessible to patients due to limited access, complicated statistical plans, and challenging to interpret medical terms. Improving knowledge through better education about scientific publications in heart failure may help patients feel more informed and empowered to ask questions and be part of the decision-making process around their care.
Source: onlinejcf.comCategories: General Medicine News, Partners & KOLsTweet
Hey ya'll, sharing my excitement this AM to see the incredible articles @JCardFail New articles from Cardiac Amyloidosis Registry Study (CARS), International Consortium on PGD, etc Plus AMAZING illustrations! JCF=your home for HF! Thx 4 sending ur science https://t.co/Cp01dowZha https://t.co/eUREFKV4xD